ADVANCED UROTHELIAL CARCINOMA
Clinical trials for ADVANCED UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for tough bladder cancer cases
Disease control Not yet recruitingThis study tests an experimental daily pill called zanzalintinib in 44 adults with advanced bladder cancer that has continued to grow after previous treatments. The goal is to see if the drug can shrink tumors or slow the cancer's progression. Participants will take the pill once…
Matched conditions: ADVANCED UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Guru Sonpavde • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New bladder cancer drug SYS6002 takes on PADCEV in Head-to-Head trial
Disease control Not yet recruitingThis Phase 2 trial compares a new drug called SYS6002 to the current standard treatment PADCEV in 100 people with advanced bladder cancer that has worsened after chemotherapy and immunotherapy. The study is not yet recruiting and will check for side effects and how well the drugs…
Matched conditions: ADVANCED UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC